43 results
8-K
EX-99.1
CELU
Celularity Inc - Ordinary Shares
7 Sep 23
Celularity Appoints Geoffrey Shiu Fei Ling, M.D., Ph.D. to its Board of Directors
4:21pm
, and other filings with the SEC. These risks and uncertainties may be amplified by current economic situations, including
inflation, supply chain issues
8-K
EX-99.1
CELU
Celularity Inc - Ordinary Shares
29 Aug 23
Celularity Announces Multi-year Research Collaboration Services Agreement with Regeneron
9:15am
, and other filings with the SEC. These risks and uncertainties may be amplified by current economic situations, including inflation, supply chain issues
424B5
CELU
Celularity Inc - Ordinary Shares
28 Jul 23
Prospectus supplement for primary offering
4:24pm
;
difficulties arising from reliance on third-party licenses, or supply-chain or manufacturing challenges;
risks from any strategic alliances or licensing
8-K
EX-99.1
CELU
Celularity Inc - Ordinary Shares
27 Apr 23
Other Events
5:01pm
. These risks and uncertainties may be amplified by current economic situations, including inflation, supply chain issues and overall economic
424B5
vfo2t
6 Apr 23
Prospectus supplement for primary offering
9:03pm
8-K
2yvu8 bnnf2af3i2uk4
6 Oct 22
Departure of Directors or Certain Officers
4:08pm
424B5
2l89y6zir2bu7j92bh
15 Sep 22
Prospectus supplement for primary offering
4:06pm
424B5
vuyx9qmvbge4vpl8a
8 Sep 22
Prospectus supplement for primary offering
8:46am
424B3
h1938ykj622i9xiy4nnu
24 Aug 22
Prospectus supplement
4:54pm
424B3
3u4lvf8b
24 Aug 22
Prospectus supplement
4:52pm
S-3
ja2hs7opzpwt0
11 Aug 22
Shelf registration
4:29pm
POS AM
9gswu9td1aua0vwion
11 Aug 22
Prospectus update (post-effective amendment)
4:23pm
POS AM
aur valkxp1z
11 Aug 22
Prospectus update (post-effective amendment)
4:20pm
8-K
EX-99.1
oada1lnh7pnzhiwkvd
17 Jun 22
Other Events
4:57pm
424B3
s89nrcc0f9abl06mi
1 Jun 22
Prospectus supplement
4:06pm